March 15, 2017 / 11:52 PM / 4 months ago

BRIEF-Catalyst Pharmaceuticals Q4 non-gaap loss per share $0.05 excluding items

1 Min Read

March 15 (Reuters) - Catalyst Pharmaceuticals Inc

* Catalyst pharmaceuticals announces fourth quarter and year-end 2016 financial results and provides corporate update

* Q4 gaap loss per share $0.05

* Q4 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S

* Q4 non-gaap loss per share $0.05 excluding items

* Catalyst pharmaceuticals inc- catalyst had no revenues in year 2016 or 2015

* Q4 revenue view $0.00 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below